Related Experiment Video
Updated: Jul 12, 2025
06:41
A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis
Published on: March 9, 2015
9.0K
Treatments for alopecia areata: a network meta-analysis
Miriam Mateos-Haro1,2, Monica Novoa-Candia3, Guillermo Sánchez Vanegas4
1Clinical Biostatistics Unit, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain.
The Cochrane Database of Systematic Reviews
|October 23, 2023
Summary
This study found that baricitinib significantly increases hair regrowth in alopecia areata patients. While other treatments show uncertain effects, baricitinib offers a promising option for managing this autoimmune condition.
Area of Science:
- Dermatology
- Autoimmune Diseases
- Clinical Trials
Background:
- Alopecia areata (AA) is an autoimmune condition causing nonscarring hair loss.
- Current treatments include immunosuppressants, hair growth stimulants, and contact immunotherapy.
- Understanding treatment efficacy and safety is crucial for managing AA, alopecia totalis (AT), and alopecia universalis (AU).
Conclusions:
- Baricitinib is an effective treatment for increasing hair regrowth in individuals with alopecia areata, with high-certainty evidence supporting its use.
- The efficacy of most other evaluated treatments remains uncertain due to limited or very low-certainty evidence.
- Further research is needed to clarify the safety profile and quality of life impact of various alopecia treatments.
